By Ken Sweet

Visa Inc. said its adjusted third-quarter profits rose by nearly double digits, as the global payments company continues to benefit from the broad shift by consumers to using credit and debit cards instead of cash.

The company said Tuesday that it earned a profit of $4.2 billion, or $2 a share, in its fiscal third quarter compared with a profit of $3.4 billion, or $1.60 a share, in the same period a year earlier. Last year's results included a $456 million legal expense. Excluding that one-time cost, Visa's adjusted profits rose 7% from a year earlier.

Visa said its payments volume rose 9% from a year earlier, while the number of processed transactions on Visa's network increased 10% from a year earlier. Visa gets a fee from merchants and businesses who use its payment network to process transactions, so Visa's profits rise and fall with the global economy as well as customers choosing to use a Visa debit or credit card over its competition or cash.

Roughly $3.799 trillion was processed on Visa's network last quarter, with the biggest growth coming from Central and Eastern Europe, the Middle East and Latin America. In the U.S., which accounts for roughly half of Visa's global payments volume, the number of payments rose 4.9%.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More